Access Cohorts of Cardiovascular and Diabetes Patients with the PINNACLE and Diabetes Collaborative Registries
What can we do for you?
As Veradigm Network solutions, the PINNACLE and Diabetes Collaborative Registries are uniquely positioned to enable real-world data analyses for these key populations at scale.
Complete this short form for a feasibility assessment, or to talk to one of our experts about your needs.
Draw More Meaningful Insights from Your Research
While randomized controlled trials (RCTs) continue to be the gold standard in drug development, generating data through RCTs is expensive, time consuming, and limited in sample size and representativeness. Broad real-world data (RWD) sets may lack the depth of information needed for desired diabetes and cardiovascular analyses.
Owned and operated by Veradigm, the PINNACLE and Diabetes Collaborative Registries provide access to high-value cohorts of RWD for research and can help facilitate ease of access to traditionally hard-to-reach cohorts of cardiovascular and diabetes patients for both life science researchers and real-world data marketplaces.
The Veradigm Registries provide access to a vast, geographically, and demographically diverse pool of patient records:
- Realize the geographic, demographic, and social diversity you need to draw more meaningful insights from your research
- Reach your recruitment goals faster with access to a large, specialized pool of non-academic, research-naïve sites for prospective, protocol driven studies
- Decrease study start-up, site activation, and patient enrollment timelines with the ability to conduct site and patient feasibility assessments
- Achieve rapid insight into protocol primary and secondary endpoints prior to study initiation with the availability of near real-time data
- Uncover a comprehensive view of real-world management and quality of four common cardiovascular conditions, heart failure (HF), coronary artery disease (CAD), atrial fibrillation (AFib), and hypertension (HTN), and diabetes
Notable case studies
Outpatient Prescription Practices in Patients with Atrial Fibrillation (From the NCDR PINNACLE Registry)
Utilizing PINNACLE data, researchers were able to rapidly evaluate the changes in real world practices to the Atrial Fibrillation guideline changes in 2016.
Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®
Disagreement exists whether HFmrEF (Heart Failure with mid-range ejection fraction) should be considered a distinct group. Through leveraging the PINNACLE Registry data, researchers were able to run a large descriptive analysis to determine if patients with HFmrEF had an atherothrombotic phenotype distinct from other forms of HF.
Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost, and burden of illness in the Diabetes Collaborative Registry
Real-world evidence is needed to complement the Cardiovascular Outcomes Trials for diabetes patients to understand the impact. Through an analysis of the Diabetes Collaborative Registry, researchers were able to understand the current use of new medications and the associated economic burden.
Eligibility of patients with type 2 diabetes for sodium glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry
Researchers assessed the proportions of patients in the Diabetes Collaborative Registry who would have met enrollment criteria for pivotal CVOTs of sodium-glucose co-transporter-2 inhibitors (SGLT-2is): EMPA-REG OUTCOME, CANVAS, DECLARE and VERTIS CV to understand the generalizability of findings from cardiovascular outcomes trials (CVOTs) to patients with type 2 diabetes (T2D) in clinical practice.
